🇺🇸

Corporate Governance

· daily

US Executive Officer Management Changes SEC — May 21, 2026

The May 21, 2026 regulatory filings reveal a period of significant leadership upheaval across US equities, with 13 CEO/President departures or successions, 8 CFO changes, and 16 director shifts, concentrated in financials, technology, and healthcare. Period-over-period analysis from the enriched data shows a clear divergence: while several companies like Jet.AI and NRG Energy are aggressively pivoting toward AI infrastructure (with Jet.AI's cash position surging from $1.8M to $13.5M but revenue collapsing 51.6% YoY), traditional sectors face margin compression and shareholder dissent. Notably, 8 of 50 filings (16%) revealed advisory say-on-pay votes with >7% opposition, signaling growing governance concerns, and 5 companies saw director elections with >10% against votes. Insider activity was limited but material: the Radian Group CEO succession ($1M base + $14M total compensation package) and Sterling Infrastructure's CEO extension with a unique 'successor-onboarding' RSU vesting condition highlight a trend toward performance-based retention. Capital allocation signals are mixed—Aebi Schmidt and Valhi declared stable dividends, while Rithm Capital's 35M share reserve increase (69.24M total) amid 15% advisory vote opposition suggests potential dilution risk. The most critical development is Glimpse Group's near-total leadership vacuum (CEO, CFO, Chair all resigned), creating acute uncertainty, while Kohl's 5.2M share plan amendment passed despite 19.8M broker non-votes signals cautious but ongoing retail restructuring.

50 high priority 50 total filings
· daily

US Corporate Board Director Changes SEC Filings — May 21, 2026

The 50 filings from May 21, 2026, reveal a significant wave of leadership transitions across US public companies, with a notable concentration in the financial and energy sectors. A key theme is the high level of shareholder dissent on executive compensation and equity plan approvals, with several companies (BankUnited, MaxLinear, ANI Pharmaceuticals) seeing 7-15% opposition, signaling growing investor activism. The data shows a clear pattern of insider confidence, with several companies appointing new CFOs and CEOs, while others like Glimpse Group and Jet.AI face near-complete leadership turnover or severe financial distress. Capital allocation remains mixed, with dividend increases at Aebi Schmidt and American Tower contrasting with ongoing cash burn at Jet.AI and leadership departures at Omega Healthcare. The most critical development is the high materiality events at Glimpse Group (9/10) and Jet.AI (9/10), which present both significant risk and potential turnaround opportunities. Overall, the filings suggest a market in transition, with companies aggressively managing succession plans while facing heightened shareholder scrutiny on governance and pay practices.

50 high priority 50 total filings
· daily

US Executive Compensation Proxy SEC Filings — May 20, 2026

This intelligence stream analyzes 8 DEF 14A proxy filings for the 2026 annual meeting season, revealing a concentrated focus on capital structure management and governance transitions. A dominant theme is the prevalence of reverse stock split proposals (Longeveron, Oragenics) and share issuance authorizations (Blink Charging, MSC Income Fund), signaling that several small-cap and micro-cap companies are actively managing stock price compliance or raising capital. Insider trading activity is notably absent across all filings, providing no direct management conviction signals. Period-over-period comparisons are largely unavailable as these proxy statements focus on governance proposals rather than financial performance. However, the filings reveal a clear pattern of companies seeking to increase equity incentives (Blink Charging, Workhorse) and authorize below-NAV share sales (MSC Income Fund), indicating a focus on retaining talent and accessing capital markets. The most critical development is the high concentration of annual meetings in late June 2026, creating a catalyst calendar for governance votes that could impact stock liquidity and dilution. Overall, the filings suggest a cautious capital allocation environment with an emphasis on survival and flexibility rather than aggressive growth.

8 high priority 8 total filings
· daily

US Executive Officer Management Changes SEC — May 20, 2026

The 50 filings reveal a significant wave of leadership transitions across US equities, with CEO departures at Choice Hotels, NusaTrip, and Wendy's, alongside CFO changes at Philip Morris, Skillz, and Caleres, among others. Period-over-period data from ChoiceOne Financial shows adjusted net income dropping sharply to $1.0M in Q1 2026 from $28.2M in full-year 2025, signaling a concerning trend in regional banking performance. Insider activity is limited, but notable shareholder dissent on compensation plans at Iridium (13.2% against say-on-pay) and Insperity (7.7% against incentive plan) suggests governance tensions. Forward-looking guidance reaffirmations at Choice Hotels, Schrodinger, and Turtle Beach provide stability amid leadership changes, while BrightSpire Capital's CEO extension with reduced bonus targets signals a potential cost-control strategy. Capital allocation remains steady with dividend declarations at Iridium and Global Medical REIT, but the lack of buyback activity across filings suggests a cautious reinvestment posture. The most critical developments include the termination for cause of NusaTrip's CEO and CFO, which raises governance red flags, and the orderly succession at Clean Harbors with its founder retiring after 46 years. Overall, the digest points to a market in transition, with leadership changes concentrated in mid-cap and small-cap firms, requiring close monitoring of execution risks and strategic shifts.

50 high priority 50 total filings
· daily

US Corporate Board Director Changes SEC Filings — May 20, 2026

This batch of 50 filings covering the period May 20, 2026, reveals a significant wave of C-suite and board-level transitions, with CEO changes at major firms like Wendy's and Choice Hotels, and CFO appointments at Philip Morris, Skillz, and Caleres. The data shows a clear trend of companies appointing internal successors or returning former executives, suggesting a preference for continuity. Forward-looking statements, including reaffirmed guidance at Choice Hotels and Turtle Beach, indicate that leadership changes are not expected to disrupt near-term financial performance. Insider activity is limited, but the extension of CEO Michael Mazzei's contract at BrightSpire Capital with reduced compensation targets presents a unique mixed signal. Overall, the market is absorbing a high volume of governance changes, which could create volatility but also opportunities for investors focused on strategic realignment.

50 high priority 50 total filings
· daily

US Executive Compensation Proxy SEC Filings — May 19, 2026

The three proxy filings reveal a period of corporate governance evolution and strategic realignment, with a notable absence of aggressive executive compensation changes. The dominant theme is the restructuring of advisory relationships, as seen in RBB Fund's proposal to add a co-adviser, which is a non-financial event for shareholders but signals operational consolidation in the asset management space. iAnthus Capital's filing is a routine governance exercise post-recapitalization, with no new compensation data, while MongoDB's proxy focuses on governance modernization (eliminating supermajority voting) and standard director elections, with no disclosed changes to executive pay. Across all three, there is a lack of period-over-period compensation trends, insider trading activity, or forward-looking financial guidance, limiting the depth of quantitative signals. The most actionable insights stem from the scheduled shareholder meetings and governance proposals, which provide near-term catalysts for monitoring shareholder sentiment and potential activist involvement. The overall sentiment is neutral, with materiality ranging from low (MongoDB) to moderate (RBB Fund), reflecting the routine nature of these filings.

3 high priority 3 total filings
· daily

US Executive Officer Management Changes SEC — May 19, 2026

This batch of 48 filings reveals a significant wave of leadership transitions across US equities, with notable CEO and CFO appointments at Rogers Corporation, Amerant Bancorp, and A. O. Smith, alongside the unexpected death of TOMI Environmental Solutions' CFO. A key theme is the high level of shareholder dissent on executive compensation, with Skyworks Solutions failing its say-on-pay vote (50.1% against) and several other companies (NOVAGOLD, Permian Resources, ACCO Brands) seeing over 20% opposition. Insider activity is limited to compensation-driven grants, but the lack of open-market purchases suggests caution. Forward-looking catalysts include Immunic's Phase 3 ENSURE trial readout by end of 2026 and Vistagen's new CMO appointment. Capital allocation trends show a focus on equity plan expansions (e.g., Roper Technologies adding 14.15M shares) rather than buybacks or dividends, signaling a bias toward employee retention. The most material event is the Skyworks say-on-pay failure, which could trigger board-level compensation reviews and potential activist interest.

48 high priority 48 total filings
· daily

US Corporate Board Director Changes SEC Filings — May 19, 2026

The 48 filings reveal a heavy focus on annual meeting outcomes and board composition changes, with several high-profile director appointments and executive transitions. Notable trends include significant shareholder dissent on executive compensation and equity plan amendments at multiple companies (e.g., ACCO Brands, Skyworks Solutions, NOVAGOLD), indicating growing investor scrutiny. Several companies appointed new CFOs or CEOs (e.g., A. O. Smith, Rogers Corp, Amerant Bancorp), signaling strategic leadership shifts. The unexpected death of TOMI Environmental's CFO and the resignation of Upstart's board member Jeff Huber highlight succession risks. Overall, the period shows active governance changes with mixed shareholder sentiment, presenting both opportunities and risks for investors.

48 high priority 48 total filings
· daily

US Executive Compensation Proxy SEC Filings — May 18, 2026

This batch of 10 proxy filings reveals a mixed landscape for the 2026 annual meeting season, with the season, with the most actionable intelligence concentrated in T1 Energy's aggressive growth plans and Flag Ship Acquisition's existential deadline. T1 Energy stands out with strong first-year operational results—2.79 GW of solar modules manufactured and $755.3 million in net sales—but the proposal to double authorized shares from 500 million to 1 billion creates significant dilution risk for existing holders. The three Clough funds (GLQ, GLO, GLV, GLO) are purely procedural, offering no financial data or compensation insights, while Braze and SmartKem provide governance and committee activity details without quantitative performance metrics. Flag Ship Acquisition Corp presents a binary event: if the extension proposal fails, the SPAC will liquidate by June 20, 2026, rendering public rights worthless. Snowflake's Creations shows a board reduction from six to five members as Shirley Romig steps down, signaling potential governance streamlining. Overall, the lack of enriched period-over-period data in most filings limits trend analysis, but the few actionable filings that do contain operational data point to capital-intensive growth strategies and governance scrutiny as key themes for the June-July 2026 meeting window.

10 high priority 10 total filings
· daily

US Executive Officer Management Changes SEC — May 18, 2026

The May 18, 2026, filing batch reveals a broad wave of planned leadership transitions across US equities, with 44 filings covering CEO, CFO, director, and key officer changes. A dominant theme is orderly succession planning, with 15+ filings showing internal promotions or planned retirements (e.g., NextEra Energy, Builders FirstSource, Eagle Bancorp Montana), signaling strong governance and reduced disruption risk. However, notable health-related disclosures (Wyndham CEO cancer diagnosis) and director resignations (Innoviva, AiXin Life) introduce uncertainty. Shareholder dissent is a recurring pattern: 6 companies (O'Reilly Automotive, Macy's, Marriott Vacations, Ultragenyx, Celcuity, ON Semiconductor) saw >10% against votes on director elections or equity plans, indicating governance friction. Capital allocation signals are mixed—T. Rowe Price reported $1.83T in assets (retirement-heavy), while Flagstar Bank extended CEO tenure amid return to profitability. No aggregate revenue or margin trends are available as filings lack financial statements, but forward-looking data points to key catalysts: FedEx Freight separation, Kyverna CAR-T approval path, and Super Micro consulting transition. Insider activity is limited but notable: Lesaka Technologies granted 1M options to Executive Chairman options at $5.00, and Fennec Pharmaceuticals issued inducement grants at $9.75. The overall risk profile is moderate, with 6 high-risk flags (Powerdyne, Altria, CVS, Aspen Aerogels, Celcuity, Macy's) and 12 positive sentiment signals, suggesting a cautiously bullish for well-governed firms.

44 high priority 44 total filings
· daily

US Corporate Board Director Changes SEC Filings — May 18, 2026

The 44 filings reveal a wave of board and C-suite changes across sectors, with notable insider departures at CVS, Hilton, and Aspen Aerogels (details missing) and planned successions at NextEra Energy, FedEx, and Builders FirstSource. Key period-over-period trends include strong shareholder support for say-on-pay at NACCO (99.7%) and Mastech (92.2%), but dissent at Macy's (78.6%) and Marriott Vacations (68.9% for equity plan). Insider activity is mixed: CEO Geoff Ballotti's health disclosure at Wyndham is a concern, while T. Rowe Price's leadership appointments signal strategic confidence. Capital allocation is stable, with no major buyback or dividend changes. The most critical development is the planned tax-free spin-off of FedEx Freight, which could unlock value. Sector themes include routine board refreshment, shareholder pushback on compensation plans, and a focus on AI and technology infrastructure appointments.

44 high priority 44 total filings
· daily

US Executive Compensation Proxy SEC Filings — May 14, 2026

Across 11 DEF 14A proxy statements filed around May 14, 2026, dominant themes include director elections (9/11 filings), advisory votes on executive compensation (6/11), auditor ratifications (7/11), and equity incentive plan expansions (2/11), signaling standard proxy season activities amid governance focus. EDAP TMS SA stands out with robust YoY HIFU revenue growth to record levels and new product launches, contrasting neutral/mixed sentiments elsewhere; no widespread period-over-period financial trends evident beyond EDAP's positive revenue and Signet's multi-year pay-vs-performance disclosures spanning FY2022-2026. High materiality events include Origin Materials' liquidation plan (10/10) and Mountain Lake's merger risks (9/10), implying bearish portfolio pressure in materials/SPAC segments. Neutral sentiment prevails (6/11), with mixed (1/11) and negative (2/11) outliers highlighting governance risks like Myomo's declassification proposal. Capital allocation leans toward equity incentives for talent retention, with no dividend/buyback mentions; upcoming June 2026 meetings form a dense catalyst calendar for votes on comp and plans.

11 high priority 11 total filings
· daily

US Executive Officer Management Changes SEC — May 14, 2026

Across 24 filings in the USA Executive & Director Changes stream (May 14, 2026), dominant themes include orderly C-suite retirements with named successors in insurance (RenaissanceRe CFO/CPO retire Dec 2026/Jan 2027, Selective CIO retires June 2026), sudden separations without detailed reasons (CSX CTO immediate exit, Ocugen CMO May 8, Xponential COO May 13), and positive board appointments in financials/biotech (AIG independent director June 1, Corbus pharma veteran ahead of ASCO). Capital allocation remains bullish with new $5B CSX share repurchase (atop $989M remaining) and $3B KeyCorp program replacing $1B prior ($280M left), signaling management confidence amid stable dividends. Annual meetings showed strong approvals but pockets of opposition (e.g., CSX director votes 299M against, Fulgent 6M withheld on director). NeoVolta outlier with 262% 9-mo revenue growth to $13.3M despite flat Q3, gross margins +20pp to 46%; no broad YoY/QoQ deterioration but diverse sectors limit portfolio trends. Implications: Succession planning enhances stability (positive for insurers), abrupt exits flag monitoring (COO/CTO roles), buybacks boost returns in transport/banks.

24 high priority 24 total filings
· daily

US Corporate Board Director Changes SEC Filings — May 14, 2026

The 24 filings reveal a surge in boardroom stability through annual meetings (Fulgent, CSX, Cushman, DMC Global, Delcath, InfuSystem) with director elections mostly passing despite notable opposition in Fulgent (up to 6M withheld for Groves) and CSX (299M against Zillmer). Executive transitions dominate, with orderly retirements and appointments (Selective CIO to interim, RenaissanceRe CFO/CPO to internal successors Jan 2027, AIG independent dir Jun 1, Standex CFO promo), but abrupt separations (CSX EVP immediate, Ocugen CMO May 8, Xponential COO May 13) raise flags. Capital allocation shines with CSX's $5B buyback atop $989M remaining and KeyCorp's $3B program replacing $1B ($280M left) plus $0.205 dividend; equity plans approved widely (Fulgent 2M+1.5M shares, Cushman 12M+, Delcath +1.8M). NeoVolta outlier with Q3 revenue flat YoY at $2M but 9-mo +262% to $13.3M, margins 46% vs 26% YoY despite wider $3M loss. Portfolio trends: Positive sentiments in 7/24 (e.g., insurance, fitness), mixed/neutral elsewhere; no broad insider selling but appointments signal conviction. Implications: Bullish for capital returns in financials/transport, monitor governance dissent and transitions for execution risks.

24 high priority 24 total filings
· daily

US Executive Compensation Proxy SEC Filings — May 13, 2026

Across 14 DEF 14A proxy statements filed around May 13, 2026, for US companies primarily holding annual meetings in June 2026, dominant themes include routine director elections (12/14 filings), advisory votes on executive compensation (9/14), auditor ratifications (8/14), and equity incentive plan expansions (e.g., BOX +7.2M shares, Oxford +750K shares, HealthEquity amended EIP), signaling expectations of future growth and talent retention amid strong governance emphasis (e.g., BOX 7/8 independent directors, Kroger all but CEO/Chair independent). Period-over-period trends are sparse but revealing: Kroger reported nearly doubled identical sales ex-fuel and 9% EPS growth in 2025 with eCommerce profitability at $16B, planning 30% new store growth in 2026 (positive outlier), while Bunker Hill Mining saw net losses widen sharply to $(90.4M) in 2025 from $(29.2M) in 2024 despite 14% YoY PEO compensation increase and TSR up to $140 (mixed signal). Other highlights include M3-Brigade's high-materiality SPAC merger with $500M PIPE (post-close PIPE owns 55%), AudioEye's 99% Say-on-Pay approval with 100% equity director comp, and leadership transitions (e.g., Perma-Pipe 3 resignations, Oxford director retirement at 72). Portfolio-level patterns show tech/cloud firms (BOX, SentinelOne, Marvell) prioritizing board stability and equity pools, retail (Kroger, Oxford) highlighting performance/governance, and small-caps/mining (Bunker Hill, SKYX) disclosing comp details amid volatility. Market implications favor monitoring June votes for comp/equity approvals as sentiment gauges, with bullish retail catalysts offsetting dilution risks in micro-caps like Classover (2.5B Class B authorization). No widespread insider selling noted, but equity-heavy comp (e.g., AudioEye RSU holdings up to 102K vested) indicates alignment.

14 high priority 14 total filings
· daily

US Executive Officer Management Changes SEC — May 13, 2026

Across 41 filings on USA Executive & Director Changes from May 13, 2026, the dominant theme is orderly leadership transitions, with 12 CEO/CFO/COO changes (e.g., HF Sinclair CFO terminated after leave, Power Solutions CEO resignation to interim CFO, Rent the Runway CEO to interim), 15+ successful annual meetings approving directors (90-99% support), comp plans, and auditors, signaling strong shareholder alignment. Financial reporters show mixed period trends: Doximity FY2026 revenue +13% YoY to $644.9M but Q4 net income -69% to $19.1M; Jack in the Box Q2 revenue -4.3% YoY, SSS -3.8%, margins -320 bps; Tango Q1 net loss +14% to $45.5M despite cash runway to 2028; Zenas Q1 net loss widened to $81M on +73% R&D. Capital allocation remains shareholder-friendly with Hanover's $700M buyback (replacing $63M remainder), Coeur's inaugural $0.02/share dividend (record May 22), and multiple LTIPs approved (e.g., MDU +6.5M shares). Positive sentiments dominate (22/41 positive, 10 neutral), with biotech/pharma showing clinical catalysts (Zenas BLA Q2 2026) amid leadership refreshes, implying sector rotation opportunities but watch CFO turnover (6 cases) for finance risks.

41 high priority 41 total filings
· daily

US Corporate Board Director Changes SEC Filings — May 13, 2026

Across 41 SEC filings on USA Board Room Changes from May 13, 2026, the dominant theme is high C-suite and board turnover, with 12 CEO/CFO/president departures or transitions (e.g., HF Sinclair CFO termination, Power Solutions CEO resignation, Rent the Runway CEO step-down) amid neutral-to-negative sentiment, signaling potential instability in energy, pharma, and tech sectors. Annual shareholder meetings (15 filings) overwhelmingly passed director elections, auditor ratifications, and equity plans with 90-99% support (e.g., Vertex 94-99%, MDU >90%), reinforcing governance stability. Period-over-period trends show mixed financials: revenue growth in Doximity (+13% FY2026 YoY to $644.9M) and cash runway extensions (Tango to 2028, Zenas to Q2 2029), but margin compression in consumer names (Jack in the Box Restaurant-Level Margin -320 bps YoY to 16.4%) and widening losses in biopharma (Tango net loss +14% to $45.5M, Zenas +141% to $81M). Capital allocation leans bullish with Hanover's $700M buyback authorization (+$637M vs prior remainder), Coeur Mining's inaugural $0.02/share dividend, and LTIP expansions (e.g., MDU +6.56M shares). Forward-looking catalysts cluster in pharma (e.g., Zenas BLA Q2 2026, Tango data readouts 2026), while leadership promotions signal continuity (e.g., Toll Brothers EVP to President). Portfolio implication: Favor stable boards with buybacks/dividends; avoid high-turnover firms until interim stability proven.

41 high priority 41 total filings
· daily

US Executive Compensation Proxy SEC Filings — May 12, 2026

Across 12 DEF 14A filings dated May 12, 2026, a dominant theme is clustered June 2026 shareholder meetings (10/12 between June 2-25) for director elections (11/12), auditor ratifications (9/12), say-on-pay votes (4/12), and advisory agreement approvals amid control changes or M&A (5/12 funds/ETFs). Period-over-period trends reveal stark contrasts: NVIDIA's explosive FY2026 revenue +65% YoY to $215.9B and EPS +67% to $4.90 outpace peers, while CarMax EPS plunged -47.7% YoY to $1.68 amid sales declines and impairments, Apogee sales edged +3% YoY but op margin contracted -270 bps to 6.0%, and funds show no financial declines but advisor disruptions. Mixed sentiment prevails (4/12 mixed), with high materiality in growth outliers (NVIDIA, CarMax 9/10) and fund transitions (MFS, Tavia 9/10). No insider trading or capital allocation shifts noted across filings, but director ownership at Dyadic (20.9%) signals alignment. Market implications include governance catalysts for volatility, potential continuity post-approvals boosting stability in funds/tech, and relative outperformance opportunities in high-growth names like NVDA versus cyclical decliners like KMX/APOG. Portfolio-level pattern: Margin compression in 3/4 detailed financials (avg -150 bps) despite uneven revenue growth, highlighting cost pressures amid transitions.

12 high priority 12 total filings
· daily

US Executive Officer Management Changes SEC — May 12, 2026

Across 50 filings in the USA Executive & Director Changes stream (43 new), the dominant theme is routine annual shareholder meetings (20+ companies) approving directors, equity incentive plans (share increases averaging 4-6M shares), say-on-pay, and auditors with strong majorities, signaling stable governance amid minor oppositions (e.g., 20% against Piedmont's plan). Executive transitions dominate (25+ cases), mostly neutral/positive retirements/appointments (e.g., new COOs/CFOs/CEOs at Standard Motor, Laser Photonics, Eagle Bancorp) with seamless handovers, though negative separations (HF Sinclair CEO/CFO) and distress (Bitcoin Depot) stand out. Period trends show robust revenue growth in growth sectors (SOLV +66% YoY Q1 rev/$93M EBITDA +174%; Arteris +39% YoY; Nextpower FY26 +20% to $3.56B; TransAct +10% YoY) but widening losses (C3.ai FY26 op loss $(217.8)M vs $(88.1)M; Bitcoin -49% YoY rev). Capital allocation favors repurchases (Progressive 25M shares, TransAct $3M) and dividends (Progressive $0.10/share July 10), while M&A (SOLV $45M acquisition) and financings (Achieve $354M) support growth. Forward-looking catalysts include FDA dates (Achieve June 20), retirements (Arteris CFO Aug 31), and guidance raises (SOLV EBITDA $435-455M FY26), implying portfolio-level stability but sector-specific alpha in tech/energy transitions.

50 high priority 50 total filings
· daily

US Corporate Board Director Changes SEC Filings — May 12, 2026

Across 50 SEC filings on USA Board Room Changes from May 12, 2026, dominant themes include orderly executive transitions (12 CEO/CFO changes, mostly retirements/appointments with successors), annual shareholder meetings (20+ with director elections and equity plan approvals, averaging 90%+ support but 20% opposition on share increases), and board expansions with industry veterans (e.g., ex-TI, Caterpillar execs). Period-over-period trends show revenue acceleration in 7 reporters (avg +37% YoY: SOLV +66%, Arteris +39%, Nextpower +20%), but mixed profitability (SOLV EBITDA +174%, yet net losses widened in HF Sinclair, Bitcoin Depot -49% YoY rev). Guidance raised in SOLV ($435-455M EBITDA), Arteris ($91-95M rev), TransAct ($1-1.75M EBITDA), signaling growth conviction amid transitions. Capital allocation favors buybacks (TransAct $3M, Progressive 25M shares) and dividends (Progressive $0.10/share). Portfolio-level patterns: Financials/healthcare see high turnover (8 changes), tech/energy mixed financials with positive board sentiment (avg materiality 7/10). Implications: Bullish stability in most changes boosts confidence; monitor financial reporters for Q2 catalysts amid 5 negative departures.

50 high priority 50 total filings